Cell Therapy Analysis

Allogene CEO David Chang Steps Down: Implications for the Biotech Sector

FDA · cell therapy · 8 min

Cencora-Kite Agreement: A New Era for CAR T-cell Therapy Commercialization

FDA · CAR T-cell therapies · 7 min

Legend Biotech's In Vivo CAR-T Data Sparks Stock Surge: A Catalyst Tracking Analysis

8 min